Health Condition 1: B079- Viral wart, unspecified
Conditions
Interventions
Intervention1: INTRALESIONAL PLATELET RICH PLASMA: INTRALESIONAL PLATELET RICH PLASMA USING 31G INSULIN SYRINGE AND KEEPING NUMBER OF PRICKS CONSTANT AT 10-12 PRICKS PER CENTIMETER SQUARE.INTERVENTION
Sponsors
RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Eligibility
Inclusion criteria
Inclusion criteria: Patients who give informed written consent and fulfilling all the following criteria will be included in the study 1.Patients aged more than twelve years and less than sixty years 2. Patients having extragenital cutaneous warts. 3. Treatment wash-off period of at least 2 weeks for topical therapy and 4 weeks for systemic therapy.
Exclusion criteria
Exclusion criteria: Patient having any of the following criteria will be excluded from the study. 1. Inflamed or ulcerated warts 2. Patient on immunosuppressant drugs 3. Chronic kidney disease, Chronic liver disease, Uncontrolled Diabetes, Uncontrolled hypertension, Coagulopathy, Thrombocytopenia. 4. HIV, Hep B, Hep C 5. Advanced stage of internal malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Investigator global assessment (Grade -1 to 5)/ Photographic assessment 2. Lesion count 3. Patient global assessment (VAS score)Timepoint: 4,8,12,16,2O WEEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life assessment using Dermatology Life Quality Index -WARTS 2. Recording of side effects, if any, as per proforma 3. Histopathology slide viewing and counting of T cells in infiltrateTimepoint: DLQI AT BASELINE AND 12 WEEKS. BIOPSY AT BASELINE AND AT 12 WEEKS(FOR NON RESOLVING LESIONS), AND BASELINE AND ANYTIME AFTER BASELINE (FOR RESOLVING LESIONS) | — |
Countries
India
Contacts
Public ContactDR SHUBHAM KUMAR
AIIMS JODHPUR
Outcome results
None listed